Evidence map›Paper›PMID 39452505›Full record

ArticleDiseases (Basel, Switzerland)2024

Characteristics of Hepatocellular Carcinoma by Sex in Mexico: A Multi-Institutional Collaboration.

Javier Melchor-Ruan, Luis Santiago-Ruiz, Blanca Olivia Murillo-Ortiz, Samuel Rivera-Rivera, Yelda A Leal-Herrera, David Suárez-García, José María Remes-Troche, Peter Grube, Gustavo Martínez-Mier, Erika Ruiz-García and 16 more

Abstract read
In one paragraph

Article in Diseases (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Javier Melchor-RuanDepartamento de Gastroenterología, Instituto Nacional de Cancerología, Ciudad de México 14080, Mexico.
Luis Santiago-RuizCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.ORCID 0000-0002-2553-4899
Blanca Olivia Murillo-OrtizUnidad de Investigación en Epidemiologia Clínica, UMAE No. 1, OOAD, Instituto Mexicano del Seguro Social, Guanajuato 37328, Mexico.
Samuel Rivera-RiveraDivisión de Atención Oncológica en Adultos, Coordinación de Atención Oncológica, Instituto Mexicano del Seguro Social, Ciudad de México 03020, Mexico.ORCID 0000-0002-4921-4195
Yelda A Leal-HerreraRegistro Poblacional de Cáncer Mérida, Unidad de Medicina de Alta Especialidad UMAE Mérida, Instituto Mexicano del Seguro Social, Mérida 97155, Mexico.ORCID 0000-0003-1308-842X
David Suárez-GarcíaUnidad de Medicina de Alta Especialidad UMAE No. 1, Instituto Mexicano del Seguro Social, León de Los Aldama 37328, Mexico.
José María Remes-TrocheUniversidad Veracruzana, Veracruz 94294, Mexico.
Peter GrubeUniversidad Veracruzana, Veracruz 94294, Mexico.
Gustavo Martínez-MierUniversidad Veracruzana, Veracruz 94294, Mexico.ORCID 0000-0002-2883-9188
Erika Ruiz-GarcíaDepartamento de Gastroenterología, Instituto Nacional de Cancerología, Ciudad de México 14080, Mexico.ORCID 0000-0002-0446-123X
Alan Ramos-MayoDepartamento de Gastroenterología, Instituto Nacional de Cancerología, Ciudad de México 14080, Mexico.
José Antonio Velarde-Ruiz-VelascoHospital Civil Guadalajara Fray Antonio Alcalde, Guadalajara 44280, Mexico.ORCID 0000-0002-6568-7048
Ricardo Gamboa-GutierrezDivisión de Oncología, Unidad de Medicina de Alta Especialidad UMAE Mérida, Instituto Mexicano del Seguro Social, Mérida 97155, Mexico.
Karla Gabriela Ordoñez-EscalanteLaboratorio de Anatomía Patológica, Unidad de Medicina de Alta Especialidad UMAE Mérida, Instituto Mexicano del Seguro Social, Mérida 97155, Mexico.
Laura Esthela Cisneros-GarzaChristus Muguerza Alta Especialidad, Monterrey 64060, Mexico.ORCID 0000-0001-9635-9971
Pilar Leal-LeyteCentro Médico Naval, CEMENAV, Ciudad de México 04470, Mexico.ORCID 0000-0002-7341-738X
Jesús Sepúlveda-DelgadoHospital Regional de Alta Especialidad Ciudad Salud, Tapachula 30830, Mexico.ORCID 0000-0003-1393-653X
María Saraí González-HuezoCentro Médico Toluca-ISSEMyM, Toluca de Lerdo 52170, Mexico.ORCID 0000-0001-6221-4088
Ricardo Arvizu-CastilloUnidad de Quemados, Hospital General de Zona # 14, Instituto Mexicano del Seguro Social, Hermosillo 83120, Mexico.
Jorge Urías-RochaUnidad de Quemados, Hospital General de Zona # 14, Instituto Mexicano del Seguro Social, Hermosillo 83120, Mexico.
Celia Beatriz Flores-de-la-TorreCentro Estatal de Oncología de Campeche, Campeche 24096, Mexico.
Leonardo Manuel Carrillo-MendozaCentro Estatal de Oncología de Campeche, Campeche 24096, Mexico.
Juan Manuel Gámez-Del-CastilloHospital General del Estado de Sonora "Dr. Ernesto Ramos Bours", Hermosillo 83000, Mexico.
Martín LajousCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.ORCID 0000-0002-8471-4128
Adriana MongeCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.
Daniel Zamora-ValdésHepatobiliary Sciences and Liver Transplantation, KASCH, KAMC, MNGHA, Ar Rimayah, Riyadh 14611, Saudi Arabia.ORCID 0000-0001-6821-1478

Funding

Aflatoxin exposure and hepatocellular carcinoma in MexicoR21TW011720 · FIC · MEXICO NATIONAL INSTITUTE OF PUBLIC HLTH · PI LAJOUS, MARTIN · 2020 to 2022
$424k
FIC NIH HHS R21 TW011720NIH HHS 1R01TW011720-02S1
6 · The paper itself

Abstract

Liver cancer is the fourth leading cause of cancer-related death worldwide. In Mexico, there is a high burden of liver cancer mortality in rural states, affecting both women and men equally. Thus, we aimed to describe the demographic and clinical characteristics of hepatocellular cancer (HCC) by sex in Mexico. Demographic and clinical information was extracted retrospectively from the medical records of patients with HCC initially treated (2015-2022) at institutions participating in a national survey across the country. The male-to-female ratio was calculated at the national and regional levels, and the results were stratified by sex. Among 697 HCC patients, the age at diagnosis was 65.4 ± 11.9 years and 20% were diagnosed at ≥75 years. The male-to-female ratio was 1.4:1, ranging from 1:1 in the northwestern and southwestern regions, to 2.1:1 in the western region. The proportion of cirrhosis was similar between the sexes; however, the etiology of cirrhosis differed: cryptogenic cirrhosis was higher in women and alcohol consumption was higher in men. Men had a higher proportion of advanced HCC, poor/undifferentiated tumors, and ≥4 nodules than women. HCC in the Mexican population affects both men and women at a 1.4:1 male-to-female ratio. This unique proportion by sex could be explained by the differences in the prevalence of risk factors across our heterogeneous country.

Indexed as

cancer epidemiologyhepatocellular carcinomaMexicosex differences

Identifiers

PMID39452505
PMCPMC11508022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.